Christopher Mutz, Head of Rare Disease: Ani Pharmaceuticals ANIP Sell · Filed 02/17

Trade details

Type: Insider sale
Amount: $538,299.6
Shares · price: 7,032 sh · $76.55 a share
Held after: 92,566 sh
Stock: Ani Pharmaceuticals ANIP
Person: Christopher MutzHead of Rare Disease
Trade date: 26/02/12
Filed: 26/02/17
Days to filing: 5 days

Sold 7.1% of holdings

Share of holding sold: 7.1%

Ani Pharmaceuticals trades, last 26 weeks

What else happened in Ani Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/13~03/14

Christopher Mutz's recent trades

Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$226.5K
3,162 sh
$226.5K
Filed 03/13
Traded 03/13
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$267.2K
3,602 sh
$267.2K
Filed 03/10
Traded 03/09
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$157.4K
2,121 sh
$157.4K
Filed 03/10
Traded 03/06
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$30.9K
417 sh
$30.9K
Filed 03/04
Traded 03/02
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$415.3K
5,323 sh
$415.3K
Filed 02/23
Traded 02/20